Baidu
map

Eur Urol:男性福利,高频射精或可降低前列腺癌风险~~

2016-04-08 Mechront&小M MedSci原创

前列腺是男性特有的性腺器官,具有内、外双重分泌功能。作为外分泌腺,前列腺每天分泌约2ml前列腺液,是构成精液的主要成分。前列腺液可真是个好东西,它能帮助精子穿过子宫颈内的黏液屏障和卵细胞的透明带;能使精子从精液中获取营养,激发精子的活力;中和女性阴道中的酸性分泌物,提高精子的成活率。 但是,前列腺也是癌症好发部位。在全球范围内前列腺癌是男性第二常见的癌症,甚至,在欧美的部分地区其发病

前列腺是男性特有的性腺器官,具有内、外双重分泌功能。作为外分泌腺,前列腺每天分泌约2ml前列腺液,是构成精液的主要成分。前列腺液可真是个好东西,它能帮助精子穿过子宫颈内的黏液屏障和卵细胞的透明带;能使精子从精液中获取营养,激发精子的活力;中和女性阴道中的酸性分泌物,提高精子的成活率。
 
但是,前列腺也是癌症好发部位。在全球范围内前列腺癌是男性第二常见的癌症,甚至,在欧美的部分地区其发病率排在了第1位;在我国,前列腺癌位居男性恶性肿瘤发病率的第6位,但是中国的前列腺癌发病率在近二十年间增长了超过10倍,且近年来该疾病的发病率和死亡率有明显的上升。因此医疗圈关于前列腺癌的研究越来越多。

去年的美国泌尿学会年会上来自波士顿哈佛大学T.H. Chan公共卫生学院的流行病学家Jennifer Rider博士介绍了他的团队的研究结果——男性可以通过高射精频率降低其患前列腺癌的风险,并给出了数据证据,这在当时引起了许多热议。上周,其更细化的研究结果在线发表在European Urology上,这让医疗圈再次聚焦在了前列腺癌风险与射精频率的关系上。
 
其实,关于这个建议并不新鲜,早在2004年,美国国家癌症研究所(NCI)癌症流行病学和遗传学部门的Michael F. Leitzmann博士和同事对29342名46-81岁的美国男性进行了前瞻性调查(1992-2000年),探究射精频率(包括性交、手淫和梦遗时的射精)和前列腺癌的关系,研究成果发表在JAMA上。
 

 
结果如上表所示,20-29岁男性中,每月射精次数≥21次 vs. 4-7次,前列腺癌风险为0.89(95% CI, 0.73-1.10);40-49岁男性,两组比较风险为0.68 (95% CI, 0.53-0.86);纳入研究前1年(1991年),风险为0.49 (95% CI, 0.27-0.88);两组比较这一生的平均风险为0.67 (95% CI, 0.51-0.89)。
 
结果表明,对于白种人男性,高频射精不会增加前列腺癌风险,或许还能够降低局限性前列腺癌风险。
 
此后,来自波士顿哈佛大学T.H. Chan公共卫生学院的流行病学家Jennifer Rider博士和同事对2004年公布的这一大型卫生健康随访研究报告进行了更新,并在2015年的美国泌尿学会年会上公布了初步观测数据。
 
该研究对约32000名男性进行了长达18年的随访(1992-2010年),研究期间,有3839名男士被诊断为前列腺癌,其中384例具有致死性。
 
控制混杂变量后,数据显示:
1.每月射精次数≥21次 vs. 4-7次的男士,患前列腺癌风险降低20%(20~29岁和40~49岁男士)。
2.在40~49岁年龄段,38.0%的男士报告称每月射精8到12次,只有8.8%报告称每月至少21次。
 
Rider博士和同事认为,安全性行为将有益于前列腺健康。不过研究者并没有发现射精频率与高危或晚期或致密性前列腺癌间的关系。
 
2016年3月28日,该研究更细化的结果论文在线发表在European Urology上,该论文再一次为“高射精频度或可降低前列腺癌风险”提供了强有力的支持证据。
 

 
结果如上表所示:
1.20-29岁男性中,每月射精次数≥21次 vs. 4-7次,前列腺癌风险为0.81(95% CI, 0.72–0.92; 趋势P < 0.0001);40-49岁男性,两组比较风险为0.78 (95% CI, 0.69–0.89; 趋势P < 0.0001);
2.40-49岁男性,每月射精8-12次的男性其前列腺癌风险方面降低10%,每月射精13-20次的男性其前列腺癌风险方面降低20%(趋势P<0.0001)。
 
与去年年会上报告的初步观测结果一致,研究者没有发现射精次数与高危或晚期或致死性前列腺癌间的关系。科学家们尚未发现造成这种例外的原因。
 
Rider博士认为,安全的性行为有益于前列腺健康。但是,他还指出,每月射精≥21次的男性通常摄入更多的卡路里、更容易感染性传播疾病、更有可能吸烟、酗酒等,并且不太愿意进行PSA筛查(与每月射精次数少的男性相比)。这些因素暴露可能使他们其他疾病的发病率和死亡率更高。因此,关于该研究,医学界还需进一步探讨。

来自西雅图Fred Hutchison癌症研究中心的前列腺癌研究人员Janet Stanford博士(并没有参与该研究)指出:
1.该研究并不能证实射精频率和前列腺癌间的因果关系。
2.这些研究数据是“高质量”的,并会在未来就两者间背后潜在的机制进行更多的研究。
 
研究者介绍说:“射精次数更多男性其前列腺癌风险的降低的一部分原因,可能是因为在被确诊为前列腺癌之前就因为其他疾病导致了死亡。”但是使用“半竞争风险模型”,研究人员发现因其他原因导致过早死亡,似乎不能解释高射精频率降低前列腺癌风险。

Rider博士也提出了一个可能的机制:一些潜在致癌的分泌物可能会积累在前列腺里,导致前列腺癌风险的增加。所以随着射精次数的增加,物质的排除,风险得以降低。

梅斯小编评:

随着近些年来的科普宣传,人们越来越多地认识到了癌症的危害,对癌症有了“早发现,早治疗,重在预防”的观念,关于癌症的预防方法也是层出不穷,其实许多的预防方法根本没有科学依据。癌症预防需要在医护人员的科学宣教下进行,而不是人云亦云。预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等。因此,医护人员、科研工作者、媒体应把更多的焦点放在造成该研究结果的原因(而不是结果)探讨上,这样才不会造成伪科学的传播,这样才能更好地促进医学的发展。
 
拓展阅读

1.秃顶也是前列腺癌的高危因素?

已被验证的前列腺癌高危因素有高龄、黑人种族、家族病史和基因突变。但是美国的研究人员发现秃顶可能也是前列腺癌的高危因素。

今年2月1日,刊登在American Journal of Epidemiology上的对美国的一项大型前瞻性纵向队列研究NHEFS的数据分析的研究指出:脱发的男性罹患前列腺癌的几率是其他人的1.5倍。

研究人员观察了4316名NHEFS队列中患者的数据,他们的年龄为25到74岁不等。分析数据后发现,秃顶者罹患致命性前列腺癌的概率比其他人高了56%(HR,1.56;95%Cl,1.02-1.37)。对于中度秃顶患者来说,风险高出了83%(HR,1.83;95%Cl,1.15-2.92)。

但是,对于被证实的高危因素,如其他研究发现,黑色人种患前列腺癌的概率是白种人的2.5倍。研究人员还不能肯定的指出秃顶也是前列腺癌的高危因素。

2.Cancer Prev Res:喝绿茶增加还是减少前列腺癌风险

英国格拉斯哥大学研究人员对6000多名男性进行长达37年的研究显示,每天喝7杯茶以上的人患前列腺癌的风险比每天喝3杯茶以下的人增加50%。他们的研究结果与先前研究称喝茶可降低患癌、心脏病、糖尿病以及帕金森病的风险相反。

不过,最新一项由Kumar NB发表的随机对照研究则证明绿茶儿茶酚使用一年,并不降低前列腺癌的风险。这项研究采用安慰剂对照,而绿茶儿茶酚混合物包括400mg 儿茶素(EGCG),每天使用,持续1年,但是,与安慰剂相比,并没有降低前列腺癌的风险。

还有一些研究则认为绿茶本身对前列腺癌作用可能并不大,但却可以增强化疗药的作用。总之,茶叶对前列腺癌的影响还存在争议,后续可能还需要更大样本,更长期,设计更严谨的研究来证实。

原始出处:
 
Michael F. Leitzmann, Elizabeth A. Platz, Ejaculation Frequency and Subsequent Risk of Prostate Cancer.JAMA. 2004;291(13):1578-1586.doi:10.1001/jama.291.13.1578.
 
 
Rider JR,Wilson KM,Sinnott JA,Kelly RS,et al.Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up.Eur Urol 2016 Mar 28;[Epub ahead of print]

Nick Mulcahy.Ejaculate More, Have Less Prostate Cancer Risk.Medscape. March 31, 2016.

Zhou CK, Levine PH, Cleary SD, Hoffman HJ, Graubard BI, Cook MB.Male Pattern Baldness in Relation to Prostate Cancer-Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study.Am J Epidemiol. 2016 Feb 1;183(3):210-7.


Kumar NB, Pow-Sang J,et al.Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate CancerPrevention.Cancer Prev Res (Phila). 2015 Oct;8(10):879-87. 


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-06-15 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-10-03 1e10c84am36(暂无匿称)

    深度好文,值得关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-04-14 李继凯

    文章不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-04-14 李继凯

    值得学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-04-13 jetleo

    预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-04-11 wwjxx

    射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-04-10 shiliang188

    这是鼓励啥呢吗!?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-04-10 shiliang188

    这是鼓励啥呢吗!?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2061523, encodeId=820a2061523ec, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Wed Jun 15 22:58:00 CST 2016, time=2016-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139448, encodeId=95bb139448a1, content=深度好文,值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 03 09:43:00 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022549, encodeId=80d6202254934, content=<a href='/topic/show?id=42b532553af' target=_blank style='color:#2F92EE;'>#前列腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32553, encryptionId=42b532553af, topicName=前列腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Mon Dec 26 14:58:00 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78189, encodeId=be0ce8189e9, content=文章不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78190, encodeId=fad1e819085, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:41:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77600, encodeId=7bd9e760006, content=预防前列腺癌,有更科学合理的方法,如运动、健康饮食、合理作息等, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Wed Apr 13 08:52:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77380, encodeId=e486e738033, content=射的多了,路上自然不会堵;可是也有精尽人亡的风险,泌尿科同道努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36431584645, createdName=wwjxx, createdTime=Mon Apr 11 07:26:00 CST 2016, time=2016-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77321, encodeId=2d51e7321e1, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77322, encodeId=46f0e73229c, content=这是鼓励啥呢吗!?, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=013c1429626, createdName=shiliang188, createdTime=Sun Apr 10 22:48:00 CST 2016, time=2016-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308436, encodeId=d94513084363d, content=<a href='/topic/show?id=b387526990e' target=_blank style='color:#2F92EE;'>#性福#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52699, encryptionId=b387526990e, topicName=性福)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76fa353, createdName=tm10051981, createdTime=Sun Apr 10 05:58:00 CST 2016, time=2016-04-10, status=1, ipAttribution=)]
    2016-04-10 tm10051981

相关资讯

EAU16:无创超声技术或可改变前列腺癌治疗方法

来自英国大学学院附属医院(UCH)的一项新的研究表明,无创超声技术可用于前列腺癌的治疗,这或可改变目前前列腺癌的治疗方法。该研究结果已于本月11-15日在德国慕尼黑举行欧洲泌尿协会大会(EAU16)上报道。研究显示,超声可有效治疗前列腺癌,其效果和手术或放疗一样,且超声治疗的副作用较少。

ASNSS 2016:碳水化合物的种类影响你的患癌风险

大多数人都知道摄入过多碳水化合物对机体健康不利,有可能导致民众出现肥胖和其他健康问题。2016年美国营养协会科学会议年度会议指出,减少摄入甜品饮料和精加工食物可降低民众患癌风险。 他们认为,食用含糖饮料和将加工食品作为午饭可使民众患前列腺癌的风险翻倍或是普通民众的3倍,但是食用豆类、水果和蔬菜可以使民众患乳腺癌的风险降低2/3。 前列腺癌是男性最常见的癌症之一,是患癌死亡男性的第二大死因,而乳腺癌

Clinical Oncology:前列腺癌患者维生素D水平普遍较低

埃文斯顿西北大学的研究人员将研究结果发表在Clinical Oncology。 这一发现对同意保守治疗的前列腺癌患者十分有利。泌尿外科副教授Adam Murphy指出,黑皮肤且维生素D摄入量低或日照量少的男性在诊断PSA升高或前列腺癌时应评估其机体维生素D水平是否正常。如果维生素D缺乏,则应补充。 研究人员发现低维生素D和恶性前列腺癌之间有某种联系,但是这些研究都是基于治疗前的血液采样得出的结论。

研究人员发现前列腺癌潜在疗法

最近发表于《Nanomedicine: Nanotechnology, Biology and Medicine》期刊的研究中,佐治亚大学(University of Georgia,UGA)研究人员创造出一种新的前列腺癌疗法,在该病的小鼠模型中表现出巨大的功效。 这种疗法被设计为抑制PAK-1蛋白质的活性。该蛋白质会促进高侵润性前列腺癌细胞的发展。 根据美国疾病控制和预防中心的数据,除了非黑

FDA受理安斯泰来新一代前列腺癌口服药物Xtandi补充新药申请

安斯泰来(Astellas)与合作伙伴Medivation近日宣布,FDA已受理新一代前列腺癌口服药物Xtandi(enzalutamide)治疗转移性去势抵抗性前列腺癌(mCRPC)的补充新药申请(sNDA),该申请纳入了来自2个头对头II研究TERRAIN和STRIVE的数据,研究结果证实Xtandi治疗mCRPC疗效显著优于比卡鲁胺(bicalutamide)。此次sNDA将更新Xtandi

BMJ:前列腺癌放疗增加了二次恶性肿瘤的风险

该研究的目的是确定前列腺癌放射治疗和随后的第二恶性肿瘤(第二原发癌)之间的关联。

Baidu
map
Baidu
map
Baidu
map